1. Epidermal growth factor induces the differential release of GP2 and amylase from AR4-2J cells.
- Author
-
Koshlukova S, Rubin RP, Withiam-Leitch M, and Aletta JM
- Subjects
- Animals, Calcium analysis, Cell Differentiation drug effects, Ceruletide pharmacology, Cycloheximide pharmacology, Dexamethasone pharmacology, GPI-Linked Proteins, Glucocorticoids pharmacology, Pancreas cytology, Pancreas drug effects, Protein Synthesis Inhibitors pharmacology, Rats, Tumor Cells, Cultured, Amylases metabolism, Epidermal Growth Factor pharmacology, Membrane Glycoproteins metabolism, Pancreas metabolism
- Abstract
Epidermal growth factor (EGF) stimulates secretion of glycoprotein 2 (GP2) in a time-and concentration-dependent manner from the AR4-2J pancreatoma cell line. Cell differentiation induced by dexamethasone treatment for 3 d, however, did not significantly alter either basal or EGF-stimulated GP2 release. Basal and EGF-stimulated GP2 release were similarly unaffected by caerulein, which promotes amylase secretion by a regulated route. A brief exposure to cycloheximide profoundly blocked EGF-evoked GP2 secretion. Furthermore, EGF-stimulated GP2 release was not accompanied by significant alterations in intracellular ionic calcium levels, in contrast to the stimulatory actions of caerulein. We conclude that EGF-stimulated release of GP2 occurs via a novel secretory pathway that is neither regulated nor constitutive as currently defined.
- Published
- 1995
- Full Text
- View/download PDF